Dr. Martens plc (LON:DOCS - Get Free Report) insider Ije Nwokori purchased 189 shares of the company's stock in a transaction dated Wednesday, June 11th. The shares were acquired at an average cost of GBX 79 ($1.07) per share, with a total value of £149.31 ($202.29).
Dr. Martens Trading Down 3.0%
LON DOCS traded down GBX 2.30 ($0.03) during mid-day trading on Friday, reaching GBX 74.20 ($1.01). 2,407,124 shares of the stock were exchanged, compared to its average volume of 2,279,323. Dr. Martens plc has a one year low of GBX 43.02 ($0.58) and a one year high of GBX 85.10 ($1.15). The stock has a 50 day simple moving average of GBX 58.18 and a 200-day simple moving average of GBX 63.54. The stock has a market cap of £720.31 million, a P/E ratio of 10.52, a P/E/G ratio of 6.40 and a beta of 0.11. The company has a debt-to-equity ratio of 127.27, a current ratio of 2.85 and a quick ratio of 1.13.
Dr. Martens (LON:DOCS - Get Free Report) last announced its earnings results on Thursday, June 5th. The company reported GBX 2.40 ($0.03) earnings per share for the quarter. Dr. Martens had a net margin of 7.89% and a return on equity of 18.91%. On average, analysts anticipate that Dr. Martens plc will post 2.5809394 EPS for the current year.
Dr. Martens Cuts Dividend
The business also recently declared a dividend, which was paid on Tuesday, April 8th. Shareholders of record on Thursday, March 6th were paid a GBX 0.85 ($0.01) dividend. This represents a yield of 1.47%. The ex-dividend date was Thursday, March 6th. Dr. Martens's dividend payout ratio (DPR) is currently 42.53%.
Analyst Ratings Changes
Separately, Royal Bank of Canada lowered their target price on shares of Dr. Martens from GBX 7,000 ($94.84) to GBX 6,000 ($81.29) and set a "sector perform" rating for the company in a research note on Monday, May 19th.
Check Out Our Latest Stock Analysis on Dr. Martens
About Dr. Martens
(
Get Free Report)
Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking
for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage
and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of
empowerment and their own individual attitude.
The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.
Recommended Stories
Before you consider Dr. Martens, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dr. Martens wasn't on the list.
While Dr. Martens currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
